(Exenatide is FDA approved as monotherapy for the management of T2DM.) Explicitly stated in the guideline for patients requiring dual or triple therapy, the AACE/ACE preferentially recommends the addition of a GLP-1 receptor agonist or a DPP-4 inhibitor (sitagliptin, saxagliptin), citing their efficacy and safety profiles as preferred agents over TZDs or sulfonylureas (SUs)
10.1111/1471-0528.12174 137 WilcoxA
What Are Some Effective Strategies For Managing Fatigue as a Side Effect of GLP-1 Medications
2025 Nov 25:259:115314
Tips for Vibrant Hair, Skin, and Joint Health Collagen is the most abundant protein in the body, found in the skin, muscles, bones, tendons, and ligaments
Expires on or after: Sep, 2027 A licensed vendor partner from your nearest location will deliver Inlife L-Glutathione Reduced 500mg | Grape Seed Extract, Vitamin C, Hyaluronic Acid Veg Capsule